Navigation Links
Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program
Date:12/18/2007

ram

The POET-2 program is a two-part registration program that will begin with a clinical study in subjects in up to 15 centers to acquire a set of ALTROPANE images which will be used to train the expert readers as is the customary requirement for clinical trials of molecular imaging agents. The second part of the planned POET-2 program involves two concurrent, multi-center Phase III trials of approximately 150 subjects each using the optimized ALTROPANE imaging protocol developed for commercial use.

About ALTROPANE Imaging Agent and Parkinsonian Syndromes (PS) Including Parkinson's Disease

ALTROPANE is a molecular imaging agent that specifically binds to the dopamine transporter (DAT) protein found on the surface of dopamine-producing neurons, making it visible during Single Photon Emission Computed Tomography or "SPECT" imaging. Since most forms of Parkinsonian Syndromes result in a decreased number of dopamine-producing cells, it would be expected that these patients also have fewer DATs than do patients without Parkinsonian Syndromes. Thus, we believe that ALTROPANE used in conjunction with SPECT imaging could be a useful test to distinguish Parkinsonian Syndrome tremors from non- Parkinsonian tremor: non-Parkinsonian patients would have more ALTROPANE- binding visible in the SPECT image, while Parkinsonian patients would have less.

There are several conditions that are considered Parkinsonian Syndromes. Parkinson's Disease is the most common form of Parkinsonian Syndrome. Other less common Parkinsonian Syndromes include multiple system atrophy (MSA), Progressive Supranuclear Palsy (PSP), and drug-induced Parkinsonism.

The International Essential Tremor Foundation estimates that as many as 10 million people in the United States are afflicted by essential tremor. Experts estimate that, each year, approximately 140,000 individuals present to their physician with new, undiagnosed movement disorders such as Parkinson's Disease and
'/>"/>

SOURCE Alseres Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Alseres Pharmaceuticals Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
6. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
7. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
8. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
9. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
10. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
11. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... , Sept. 17, 2014 BRIC ... Summary GlobalData,s new report, "BRIC ... market data on the BRIC Gynecological Devices market. ... dollars, volume (in units) and average prices (in ... Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization ...
(Date:9/17/2014)... , Sept. 17, 2014 The ... the last decade due to the recession, ... and technological advancements. This BCC Research report ... segments of the ambulance and emergency medical ... blood and hemorrhage control devices, equipment used ...
(Date:9/17/2014)... 17, 2014 Pomerantz LLP is investigating claims ... BioPharma" or the "Company") (NASDAQ: PDLI).  Such investors are ... rswilloughby@pomlaw.com or 888-476-6529, ext. 237. ... its officers and/or directors have violated Sections 10(b) and ... On September 17, 2014, the Company announced ...
Breaking Medicine Technology:BRIC Gynecological Devices Market Outlook to 2020 2BRIC Gynecological Devices Market Outlook to 2020 3Ambulance and Emergency Equipment: Global Markets 2Ambulance and Emergency Equipment: Global Markets 3Ambulance and Emergency Equipment: Global Markets 4SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PDL BioPharma, Inc. - PDLI 2
... Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... subsidiaries, Valeant Pharmaceuticals North America LLC (VPNA) and ... agreement to acquire the assets of the Ortho ... pay Janssen $345 million for the assets, which ...
... Inc. (Nasdaq: CPIX ) announced today that ... market closes on Thursday, August 4, 2011.  A conference call ... 4, 2011, at 5:00 p.m. Eastern Time to discuss the ... 877-303-1298 (for U.S. callers) or 253-237-1032 (for international callers).  A ...
Cached Medicine Technology:Valeant Pharmaceuticals Agrees to Acquire Ortho Dermatologics 2Valeant Pharmaceuticals Agrees to Acquire Ortho Dermatologics 3
(Date:9/18/2014)... 2014 “Awesome” is the way Emily ... Accepting Responsibility Today) Internship Program at ARDX ( http://www.ardx.net ... describe the program as “Inspirational” and “Life-changing,” respectively. ... what they would be doing during their summer internship. ... runs and other mindless tasks,” but, instead she was ...
(Date:9/18/2014)... September 18, 2014 T-System Inc. ... electronic physician documentation system — EV™ for ... , After assessing several best-of-breed solutions, Holyoke chose ... with optimizing physician productivity and reimbursement, but also ... which will still be used to capture emergency ...
(Date:9/18/2014)... By Maureen Salamon ... (HealthDay News) -- Migraines in midlife may be associated ... movement disorders in later years, new research suggests. ... between the two brain-based conditions, also suggested that the ... by aura. An aura is a warning sign of ...
(Date:9/18/2014)... Chino Hills, CA (PRWEB) September 18, 2014 ... boot camp, is the fastest-selling fitness business in the country ... to work out, has continued to grow enormously in 2014. ... Boot Camp World Conference, is taking place in Costa Mesa, ... be one of the biggest conferences yet. Founder Bedros Keuilian, ...
(Date:9/18/2014)... How much is a serving? ... factors contributing to the obesity epidemic in the United ... and how to manage portion size during the next ... at Humility House, 755 Ohltown Road, Austintown. , Registered ... informational discussion and answer questions from 12:30 to 2 ...
Breaking Medicine News(10 mins):Health News:ARDX Internship Helps Students to START on the Right Business Path 2Health News:ARDX Internship Helps Students to START on the Right Business Path 3Health News:ARDX Internship Helps Students to START on the Right Business Path 4Health News:Holyoke Medical Center ER Improves Productivity and Reimbursement with T-System 2Health News:Are Migraines in Middle Age Tied to Raised Parkinson's Risk Later? 2Health News:Are Migraines in Middle Age Tied to Raised Parkinson's Risk Later? 3Health News:With Fit Body Boot Camp World Conference Nearing, Founder Explains the Fitness Boot Camp Franchise’s Success 2Health News:With Fit Body Boot Camp World Conference Nearing, Founder Explains the Fitness Boot Camp Franchise’s Success 3Health News:HMHP Workshop Addresses Portion Control 2
... Improve Health, MADISON, Wis., June 2 The ... now studies have linked poor,indoor air quality to the ... also a variety of other health issues, including heart,disease, ... prove poor indoor air quality can cause or,contribute to ...
... 15% of their daily calories, study finds , , MONDAY, June ... more sugary beverages and fruit juices than ever before, a ... now take in up to 15 percent of their total ... confirms previous research and suggests consumption is rising. , It,s ...
... papers outlining the progress made on the ... being published in the June 2008 issue ... Written by experts representing the global ... scientific and technological approaches to implementing ICH* ...
... in Pediatrics and led by researchers at Columbia University ... (SSBs) are an increasingly large part of children and ... sodas, fruit drinks and punches, and sports drinks, drink ... increase from 10 years earlier. The findings suggest ...
... June 2 Medical Simulation Corporation (MSC),announces ... Foundation (SSF) to,provide simulation training and education ... at the SSF world-class,training facility in Seattle, ... training in surgical and endovascular,procedures, using didactic ...
... to its growing family of CCRCs with expansion ... WEST POINT, Pa., June 2 ACTS Retirement-Life,Communities, ... it has completed its acquisition of Carlton Cove, ... The,community will be renamed Magnolia Trace and become ...
Cached Medicine News:Health News:Studies Find Poor Indoor Air Quality Can Lead to Major Health Problems 2Health News:Studies Find Poor Indoor Air Quality Can Lead to Major Health Problems 3Health News:Kids Gulping Down More Sugary Beverages 2Health News:Kids Gulping Down More Sugary Beverages 3Health News:Reshaping pharmaceutical quality 2Health News:Children's consumption of sugar-sweetened beverages 2Health News:Children's consumption of sugar-sweetened beverages 3Health News:Medical Simulation Corporation Announces Partnership With Seattle Science Foundation 2Health News:ACTS Retirement-Life Communities Completes Carlton Cove Acquisition 2
Daubenspeck sharp curette, 8....
Bruns bone curette, 9, oval, solid actagonal handle....
MRI curette, 8.5" overall length....
15" overall length, 5" handle....
Medicine Products: